GlaxoSmithKline
Glaxo makes open offer to hike stake in Indian arm
26 Nov 2012
The company is offering Rs3,900 per share, a premium of approximately 28 per cent to the company's closing share price on the NSE on Friday
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 Jul 2012
US biopharmaceutical company Human Genome Sciences yesterday agreed to be acquired by GlaxoSmithKline Plc (GSK) for a sweetened $3 billion
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 Jul 2012
GlaxoSmithKline is close to acquiring Human Genome Sciences for about $2.8 billion, two months after it went hostile with its $2.59-billion bid for the US biopharmaceutical firm
GlaxoSmithKline to pay record $3 billion in US drug fraud case
03 Jul 2012
GlaxoSmithKline plc (GSK) will pay a record $3 billion to various health authorities in the US in the largest healthcare fraud settlement in US history
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 Jun 2012
No rival bids have emerged so far since GSK has invested $125 million in an ongoing research partnership with HGS and the two are collaborating on the development of three drugs
Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid
18 May 2012
HGS, which is GSK's partner on two drug developments, had rejected the UK firm's takeover offer saying that it was an opportunistic move
